載入...
Strategic and Statistical Considerations on the QT Assessment of Volasertib
Volasertib is a selective cell cycle kinase inhibitor that induces mitotic arrest and apoptosis by targeting Polo-like kinase (Plk). A potential for prolonged QT intervals was indicated with volasertib in preclinical studies and preliminary clinical data. As a result, electrocardiograms (ECGs) have...
Na minha lista:
| 發表在: | Ther Innov Regul Sci |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6047300/ https://ncbi.nlm.nih.gov/pubmed/29714574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2168479017739826 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|